Peptide-loaded hydrogel combines anti-inflammatory and bone-building effects to heal bone defects
A multifunctional hydrogel co-loaded with osteogenic peptide P24 and antioxidant nanozymes accelerated bone regeneration by reducing inflammation, promoting blood vessel growth, and enhancing bone formation in animal models.
Quick Facts
What This Study Found
The triple-component hydrogel (RGD@DEXMA/DOPA-P24/Mn3O4) synergistically reduced ROS-driven inflammation, promoted M1-to-M2 macrophage polarization and angiogenesis, and enhanced osteogenic differentiation of bone marrow stem cells, accelerating bone defect regeneration in vivo.
Key Numbers
Mn3O4 nanozymes scavenged ROS and induced M1-to-M2 macrophage polarization. DOPA moiety enabled sustained release of P24 peptide. RGD sequence promoted BMSC adhesion and proliferation. Tested in vivo in bone defect models.
How They Did This
In vitro cell culture studies with BMSCs and macrophages plus in vivo bone defect models in animals, evaluating ROS scavenging, macrophage polarization, angiogenesis, and bone regeneration.
Why This Research Matters
Bone defects often heal poorly because excessive inflammation disrupts the cooperation between immune cells and bone-forming cells. This hydrogel addresses both problems simultaneously—calming inflammation while actively promoting bone growth through sustained peptide release—offering a potential advance in regenerative orthopedic materials.
The Bigger Picture
This study exemplifies a growing trend in regenerative medicine: combining bioactive peptides with immunomodulatory agents in a single scaffold to address both the inflammatory and regenerative phases of tissue repair. If translatable to humans, such multifunctional biomaterials could improve outcomes in complex fractures and large bone defects.
What This Study Doesn't Tell Us
The study used animal models, and results may not directly translate to human bone healing. Long-term safety and degradation profiles of the nanozyme component were not extensively characterized. Specific quantitative outcomes (e.g., bone volume fractions) were not highlighted in the abstract.
Questions This Raises
- ?How would this hydrogel perform in larger, clinically relevant bone defect models?
- ?What is the long-term fate and safety profile of Mn3O4 nanozymes in vivo?
- ?Could the P24 peptide component be effective without the nanozyme in less inflammatory contexts?
Trust & Context
- Key Stat:
- Triple-action scaffold Combines anti-inflammatory, pro-angiogenic, and osteogenic functions in one hydrogel for bone repair
- Evidence Grade:
- Preclinical study with both in vitro mechanistic data and in vivo animal bone defect models. Promising but not yet tested in humans.
- Study Age:
- Published in 2025; represents current state-of-the-art in peptide-functionalized bone scaffolds.
- Original Title:
- RGD-grafted dextran methacrylate hydrogel incorporating osteogenic peptide and Mn3O4 nanozymes for enhanced bone defect healing.
- Published In:
- Materials today. Bio, 35, 102436 (2025)
- Authors:
- Pang, Yuxuan(2), Wang, Xin(4), Zhang, Huan, Li, Xin, Lin, Min, Cheng, Liang, Yang, Ying-Wei
- Database ID:
- RPEP-12940
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is the P24 peptide used in this study?
P24 is a synthetic osteogenic peptide derived from bone morphogenetic protein-2 (BMP-2) that promotes bone marrow stem cells to differentiate into bone-forming cells. In this hydrogel, it was modified with DOPA for sustained release.
Why is reducing inflammation important for bone healing?
Excessive reactive oxygen species and pro-inflammatory macrophages disrupt the communication between immune cells and bone-forming cells, delaying regeneration. By shifting macrophages to an anti-inflammatory state, the hydrogel creates a more favorable environment for bone repair.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12940APA
Pang, Yuxuan; Wang, Xin; Zhang, Huan; Li, Xin; Lin, Min; Cheng, Liang; Yang, Ying-Wei. (2025). RGD-grafted dextran methacrylate hydrogel incorporating osteogenic peptide and Mn3O4 nanozymes for enhanced bone defect healing.. Materials today. Bio, 35, 102436. https://doi.org/10.1016/j.mtbio.2025.102436
MLA
Pang, Yuxuan, et al. "RGD-grafted dextran methacrylate hydrogel incorporating osteogenic peptide and Mn3O4 nanozymes for enhanced bone defect healing.." Materials today. Bio, 2025. https://doi.org/10.1016/j.mtbio.2025.102436
RethinkPeptides
RethinkPeptides Research Database. "RGD-grafted dextran methacrylate hydrogel incorporating oste..." RPEP-12940. Retrieved from https://rethinkpeptides.com/research/pang-2025-rgdgrafted-dextran-methacrylate-hydrogel
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.